tirzepatide egfr 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( GLP therapies have established themselves

Beyond the Basics: Advanced Considerations for Researchers Mastering reconstitution is the first step

Assessment of progression of pulmonary fibrosis based on metabonomics and analysis of intestinal microbiota

When peptides are inserted in the human body, they trigger your immune system to fight against viruses and bacteria

Weight Loss Retatrutides average weight loss is impressive when compared to many other obesity medications

Continue Your Lymphedema Education As obesity, chronic edema, and lymphatic disorders continue to rise, specialized training is more important than ever

Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus